Role of Dopamine Receptors in the Anticancer Activity of ONC201
2017 · Neoplasia · 121 citations
https://doi.org/10.1016/j.neo.2017.10.002
A
Amriti R. Lulla
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
133
Papers
897
Citations
13
h-index
17
i10-index
Amriti R. Lulla is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Protease and Inhibitor Mechanisms & Cancer-related Molecular Pathways & Nanoplatforms for cancer theranostics. The author has an h-index of 13, co-authored 114 publications.
ORCID: 0000-0002-7085-5755Papers by this author
worksCancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
2017 · PLoS ONE · 44 citations
https://doi.org/10.1371/journal.pone.0180541
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9
2021 · Neoplasia · 27 citations
https://doi.org/10.1016/j.neo.2021.01.004
Preclinical evaluation of the imipridone family, analogues of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
2017 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.4993868.v1
Supplementary Data 1 from Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523427.v1
Figure S9 from Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25523430
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat